Publications

• DOJ Antitrust Announces New Policies on Antitrust Compliance Programs
  15 July 2019
  Daniel M. Abuhoff
  ,
  Ted Hassi
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Bruce E. Yannett
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• Employee “No-Poach” Agreements Draw Antitrust Attention and Debate
  15 March 2019
  Daniel M. Abuhoff
  ,
  Ted Hassi
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• FTC Announces Annual Adjustments to HSR Act and Clayton Act Section 8 Thresholds
  4 March 2019
  Daniel M. Abuhoff
  ,
  Ted Hassi
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Kyra K. Bromley
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• AT&T/Time Warner Merger Clearance Paves Way for Future Transactions
  13 June 2018
  Daniel M. Abuhoff
  ,
  Michael Diz
  ,
  Gary W. Kubek
  ,
  William D. Regner
  ,
  Michael Schaper
• FTC Expands Scope of Reportable Pharma Patent Licenses under the Hart-Scott-Rodino Act
  8 November 2013
  Daniel M. Abuhoff
  ,
  Kyra K. Bromley
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• Supreme Court Says ‘Reverse Payment’ Generic Drug Settlements Are Subject to Rule of Reason Antitrust Review
  18 June 2013
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• EU Commission Ends Antitrust Proceeding After Areva and Siemens Agree to Limit Scope of Non-Compete and Confidentiality Obligations
  29 June 2012
  Dr. Thomas Schürrle
  ,
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Timothy McIver
• Third Circuit Approves Broad De Beers Diamond Settlement Class, But Does It Also Reopen the Door for Certification of Multistate Litigation Classes?
  22 December 2011
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• FTC Implements Revisions to HSR Premerger Filing Requirements
  12 July 2011
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Kyra K. Bromley
• Head of Senate Subcommittee on Antitrust Sounds Alarm on Drug Shortages
  26 May 2011
  Daniel M. Abuhoff
  ,
  Andrew L. Bab
  ,
  Kevin Rinker
• Useful Products / Useful Ruling: Supreme Court Limits Scope Of CERCLA Arranger Liability
  12 May 2009
  Daniel M. Abuhoff
  ,
  Stuart Hammer
  ,
  Harry Zirlin
• "Sell" Means Sell, Even in a Depressed Market: DOJ and Court Require Acquiring Party to Complete Antitrust Divestiture
  13 April 2009
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Kyra K. Bromley
• A Tougher Standard for Class in Antitrust Action
  9 January 2009
  Competition Law360
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• New Decision Supports Tougher Standard for Class Certification in Antitrust Actions
  6 January 2009
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• The Private Equity Report
  Summer 2008
  Franci J. Blassberg
  ,
  E. Drew Dutton
  ,
  Robert F. Quaintance, Jr.
  ,
  Daniel M. Abuhoff
  ,
  Maurizio Levi-Minzi
  ,
  Kenneth J. Berman
  ,
  Katherine Ashton
  ,
  Jonathan F. Lewis
  ,
  Elizabeth Pagel Serebransky
• The Private Equity Report
  Spring 2004
  Franci J. Blassberg
  ,
  Kenneth J. Berman
  ,
  Geoffrey Kittredge
  ,
  Dr. Thomas Schürrle
  ,
  Margaret Andrews Davenport
  ,
  Daniel M. Abuhoff
  ,
  John M. Vasily
  ,
  Mark W. Friedman
  ,
  Gary W. Kubek
  ,
  William D. Regner
  ,
  Dr. Thomas Schürrle
  ,
  Michael P. Harrell
  ,
  Jeffrey J. Rosen
• The Private Equity Report
  Fall 2002
  Gregory V. Gooding
  ,
  William D. Regner
  ,
  Woodrow W. Campbell, Jr.
  ,
  Robert J. Cubitto
  ,
  Daniel M. Abuhoff
  ,
  Kenneth J. Berman
  ,
  Franci J. Blassberg
• The Private Equity Report
  Winter 2001
  Jennifer J. Burleigh
  ,
  Franci J. Blassberg
  ,
  William D. Regner
  ,
  David J. Schwartz
  ,
  Peter J. Loughran
  ,
  Kevin M. Schmidt
  ,
  Daniel M. Abuhoff
  ,
  Woodrow W. Campbell, Jr.
  ,
  Gary W. Kubek